17460563

Source:http://linkedlifedata.com/resource/pubmed/id/17460563

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0022885, umls-concept:C0023884, umls-concept:C0023895, umls-concept:C0026336, umls-concept:C0205088, umls-concept:C0376209, umls-concept:C0449820, umls-concept:C0456081, umls-concept:C1280500, umls-concept:C1441506, umls-concept:C1555306, umls-concept:C1706778, umls-concept:C1948033, umls-concept:C2827666
pubmed:issue	7
pubmed:dateCreated	2007-4-26
pubmed:abstractText	The use of the Model for End-Stage Liver Disease (MELD) score to prioritize patients on liver waiting lists must take the bias of different laboratories into account.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0132144
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Bilirubin, http://linkedlifedata.com/resource/pubmed/chemical/Creatinine
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0041-1337
pubmed:author	pubmed-author:BallardiniGiorgioG, pubmed-author:BegliominiBrunoB, pubmed-author:BianchiFrancesco BiancoFB, pubmed-author:CapelliMaurizioM, pubmed-author:CavriniGiuliaG, pubmed-author:Di BenedettoFabrizioF, pubmed-author:FaenzaStefanoS, pubmed-author:GerundaGiorgio EnricoGE, pubmed-author:GraziGian LucaGL, pubmed-author:MasettiMicheleM, pubmed-author:PinnaAntonio DanieleAD, pubmed-author:RavaioliMatteoM, pubmed-author:RidolfiLorenzaL, pubmed-author:VenturoliNicolaN
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	83
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	919-24
pubmed:meshHeading	pubmed-meshheading:17460563-Adult, pubmed-meshheading:17460563-Area Under Curve, pubmed-meshheading:17460563-Bilirubin, pubmed-meshheading:17460563-Carcinoma, Hepatocellular, pubmed-meshheading:17460563-Creatinine, pubmed-meshheading:17460563-Diagnostic Tests, Routine, pubmed-meshheading:17460563-Female, pubmed-meshheading:17460563-Humans, pubmed-meshheading:17460563-Laboratories, pubmed-meshheading:17460563-Liver Diseases, pubmed-meshheading:17460563-Liver Failure, Acute, pubmed-meshheading:17460563-Liver Neoplasms, pubmed-meshheading:17460563-Liver Transplantation, pubmed-meshheading:17460563-Male, pubmed-meshheading:17460563-Middle Aged, pubmed-meshheading:17460563-Observer Variation, pubmed-meshheading:17460563-Patient Dropouts, pubmed-meshheading:17460563-Patient Selection, pubmed-meshheading:17460563-Reference Values, pubmed-meshheading:17460563-Reproducibility of Results, pubmed-meshheading:17460563-Resource Allocation, pubmed-meshheading:17460563-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment.
pubmed:affiliation	Liver and Multiorgan Transplantation, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
pubmed:publicationType	Journal Article